Bacterial Infections
Summary
- The Infectious Diseases Society of America/Society for Healthcare Epidemiology of America guidelines recommend oral vancomycin or oral fidaxomicin as preferred agents and metronidazole as an alternative agent or for more mild disease (Management Guidelines)[IDSA/SHEA CDI]
- Fulminant disease is addressed with high-dose oral vancomycin
- Patients with C difficile infection should discontinue use of implicated agents when possible and avoid antiperistaltic agents and narcotics (Management Guidelines)[ACG CDI]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content